Forte Steve reported RPTX

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001815428-26-000002

Machine-readable

Structured copy

Timestamps

Event (reported)

Jan 28, 2026

Published

Jan 28, 2026

Ingested by INSIDER

Nov 5, 04:20 UTC

Last re-read

Nov 5, 04:20 UTC

Extracted facts

Filer

Forte Steve

Role

EVP, CHIEF FINANCIAL OFFICER

Transaction

Disposition to issuerAs filed: “D”

Asset

Repare Therapeutics Inc. — Employee Stock Option (right to buy)

Ticker

RPTX

Shares

85.0K

Price per share

$0

Execution date (reported)

Jan 28, 2026

Owned after transaction

0 shares

Days from execution to publication

0

What this establishes

Forte Steve filed this Form 4 reporting a disposition to issuer of RPTX on Jan 28, 2026. It became public on Jan 28, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

EVP, CHIEF FINANCIAL OFFICER

Forte Stevecik:0001815428

Issuer

Repare Therapeutics Inc.cik:0001808158

Revision history · 0

No field has changed since this record was first ingested.